You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Flumazenil

Showing 1 - 25 of 89
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Flumazenil Adverse Reaction, Remimazolam, Hip Joint Trial (Flumazenil, normal saline)

Not yet recruiting
  • Flumazenil Adverse Reaction
  • +3 more
  • Flumazenil
  • normal saline
  • (no location specified)
Jul 11, 2023

Anesthesia, General Trial in Seoul (Flumazenil)

Not yet recruiting
  • Anesthesia, General
  • Flumazenil
  • Seoul, Korea, Republic of
    Korea University Guro Hospital
Jan 25, 2023

Anesthesia Trial in Daegu (Remimazolam, Desflurane)

Recruiting
  • Anesthesia
  • Daegu, Korea, Republic of
    Daegu Catholic University Medical Center
Mar 20, 2023

Recovery Trial in Seoul (Remimazolam Besylate, Flumazenil, Propofol)

Not yet recruiting
  • Recovery
  • Remimazolam Besylate
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jul 18, 2022

Parkinson Disease Trial in Ann Arbor (Flumazenil, Placebo)

Completed
Has Results
  • Parkinson Disease
  • Flumazenil
  • Placebo
  • Ann Arbor, Michigan
    University of Michigan Functional Neuroimaging, Cognitive and Mo
Jun 4, 2022

Flumazenil Adverse Reaction, Ambulatory Surgery, Postoperative Nausea Trial in Seoul (Flumazenil)

Not yet recruiting
  • Flumazenil Adverse Reaction
  • +3 more
  • Flumazenil
  • Seoul, Seoul-T'ǔkpyǒlshi, Korea, Republic of
    Konkuk University Medical Center
May 18, 2022

Recovery Trial in Seoul (REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for SOLUTION [BYFAVO],

Not yet recruiting
  • Recovery
  • REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for SOLUTION [BYFAVO]
  • +2 more
  • Seoul, Korea, Republic of
    Department of Anesthesiology and Pain Medicine, Seoul National U
Jul 29, 2022

Parkinson Disease Trial in Ann Arbor (Clarithromycin (Not used as of 4/2020), Placebo (Not used as of 4/2020), Transdermal

Completed
  • Parkinson Disease
  • Clarithromycin (Not used as of 4/2020)
  • +3 more
  • Ann Arbor, Michigan
    University of Michigan Health System Functional Neuroimaging, Co
Mar 22, 2022

Anesthesia, Intravenous Trial in Seoul (remimazolam-based TIVA, propofol-based TIVA)

Recruiting
  • Anesthesia, Intravenous
  • remimazolam-based TIVA
  • propofol-based TIVA
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jan 11, 2022

Endobronchial Metastases, Bronchoesophageal Fistula, General Anesthetic Drug Adverse Reaction Trial in Hanzhou (Remimazolam,

Recruiting
  • Endobronchial Metastases
  • +2 more
  • Hanzhou, China
    Zhejiang Cancer Hospital
Jul 19, 2022

Brain Death, Anoxic Brain Injury, Cardiac Arrest Trial in Columbia (Flumazenil, Naloxone)

Withdrawn
  • Brain Death
  • +4 more
  • Columbia, South Carolina
    PRISMA Health Midlands
Jul 20, 2021

Hypoactive Delirium Trial in Sacramento (Flumazenil, Placebo)

Terminated
Has Results
  • Hypoactive Delirium
  • Flumazenil
  • Placebo
  • Sacramento, California
    UC Davis Medical Center
Jul 8, 2020

Fragile X Syndrome (FXS), Idiopathic Intellectual Developmental Disorder (IDD) Trial in Stanford ([18F]flumazenil)

Terminated
  • Fragile X Syndrome (FXS)
  • Idiopathic Intellectual Developmental Disorder (IDD)
  • Stanford, California
    Stanford University
Jan 25, 2021

Hepatic Encephalopathy, Liver Cirrhosis Trial in New Haven (Flumazenil, Placebo)

Withdrawn
  • Hepatic Encephalopathy
  • Liver Cirrhosis
  • Flumazenil
  • Placebo
  • New Haven, Connecticut
    Yale Psychological Medicine Research Center
Jul 3, 2020

Moderate Sedation, Colonoscopy Trial in Taipei (flumazenil, Placebos)

Unknown status
  • Moderate Sedation
  • Colonoscopy
  • flumazenil
  • Placebos
  • Taipei, Taiwan
  • +1 more
Mar 30, 2020

Mild Traumatic Brain Injury and Post-Traumatic Stress Disorder

Withdrawn
  • Posttraumatic Stress Disorder
  • Traumatic Brain Injury
    • (no location specified)
    Dec 14, 2019

    Respiratory Disease, Tracheal Stenosis, Endobronchial Mass Trial (Remimazolam besylate, Propofol)

    Not yet recruiting
    • Respiratory Disease
    • +2 more
    • (no location specified)
    Apr 18, 2023

    Induction of Anesthesia Trial (Remimazolam combined propofol, Remimazolam, Propofol)

    Not yet recruiting
    • Induction of Anesthesia
    • Remimazolam combined propofol
    • +2 more
    • (no location specified)
    Jun 17, 2022

    Sedation Complication, Midazolam, Remimazolam Trial in Beijing, Haidian (Fentanyl, Flurbiprofen, Midazolam)

    Completed
    • Sedation Complication
    • +2 more
    • Beijing, Beijing, China
    • +1 more
    Mar 12, 2022

    Impact of CES1 Genotype on Remimazolam

    Not yet recruiting
    • American Society of Anesthesiologists (ASA) Class 1-2
    • +3 more
    • Remimazolam besylate
    • (no location specified)
    Apr 24, 2023

    Cognitive Dysfunction Trial in West Haven (iomazenil)

    Completed
    • Cognitive Dysfunction
    • West Haven, Connecticut
      VHA Connecticut
    Jul 21, 2022

    Postoperative Complications Trial (Unblinded postoperative vital sign monitoring, Blinded postoperative vital sign monitoring)

    Not yet recruiting
    • Postoperative Complications
    • Unblinded postoperative vital sign monitoring
    • Blinded postoperative vital sign monitoring
    • (no location specified)
    Nov 9, 2023

    Remimazolam and Sevoflurane Anesthesia on Recovery in Pediatric

    Not yet recruiting
    • Ophthalmic Abnormalities
    • Pediatric Disorder
    • general anesthesia with remimazolam
    • Yangsan, Korea, Republic of
      Pusan National University Yangsan Hospital
    Sep 23, 2023

    Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis Trial (PET with [11C]Flumazenil)

    Unknown status
    • Multiple Sclerosis
    • Relapsing-Remitting Multiple Sclerosis
    • PET with [11C]Flumazenil
    • (no location specified)
    Jan 30, 2019

    Alcohol Dependence Trial in Charleston (Flumazenil and Gabapentin, Placebo)

    Completed
    Has Results
    • Alcohol Dependence
    • Flumazenil and Gabapentin
    • Placebo
    • Charleston, South Carolina
      MUSC-Center for Drug and Alcohol Programs
    Feb 8, 2019